These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8032568)

  • 1. Tumour markers.
    Pandha HS; Waxman J; Sikora K
    Br J Hosp Med; 1994 Mar 16-Apr 5; 51(6):297-303. PubMed ID: 8032568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour markers.
    Pandha HS; Waxman J
    QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenes and oncoproteins as tumor markers.
    Pillai R
    Eur J Surg Oncol; 1992 Oct; 18(5):417-24. PubMed ID: 1426290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum tumour markers in clinical practice. Some general aspects.
    Kvinnsland S
    Scand J Clin Lab Invest Suppl; 1991; 206():6-11. PubMed ID: 1947761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of tumour markers in clinical practice].
    Keuren JF; Thomas CM; Bonfrèr JM; Sweep CG; Boonstra JG
    Ned Tijdschr Geneeskd; 2009; 153():A617. PubMed ID: 19857306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations.
    Verma M; Manne U
    Crit Rev Oncol Hematol; 2006 Oct; 60(1):9-18. PubMed ID: 16829121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Basic concepts in the use of tumor markers in the diagnosis and follow-up of malignant bladder neoplasms].
    Moreno Sierra J; Gómez Ruiz JJ; Ortega Heredia MD; Blanco Jiménez E; Silmi Moyano A; Blázquez Izquierdo J; Corral Rosillo J; Rodríguez Molina J; Ramírez Fernández JC; Resel Estévez L
    Arch Esp Urol; 1993 Apr; 46(3):187-98. PubMed ID: 8512354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Future prospects for the use of tumor markers].
    Grunicke H
    Wien Klin Wochenschr; 1989 Jul; 101(14):472-5. PubMed ID: 2672607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of predictive values of tumor markers.
    Roulston JE
    Methods Mol Med; 2004; 97():13-27. PubMed ID: 15064482
    [No Abstract]   [Full Text] [Related]  

  • 10. AUA issues a policy report on PSA monitoring. The American Urological Association.
    Scott Morey S
    Am Fam Physician; 2000 Aug; 62(4):883-4. PubMed ID: 10969861
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical markers in oncology. Part I: molecular basis. Part II: clinical uses.
    Voorzanger-Rousselot N; Garnero P
    Cancer Treat Rev; 2007 May; 33(3):230-83. PubMed ID: 17433551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of tumor markers for screening and diagnosis (except prognostic and surveillance values) in primary bronchial cancers].
    Grivaux M
    Rev Mal Respir; 1997 Apr; 14 Suppl 3():S15-9. PubMed ID: 9229742
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening tests for hepatocellular carcinoma.
    Marrero JA
    Clin Liver Dis; 2005 May; 9(2):235-51, vi. PubMed ID: 15831271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to judge a tumor marker.
    Katz EM; Kattan MW
    Nat Clin Pract Oncol; 2005 Oct; 2(10):482-3. PubMed ID: 16205748
    [No Abstract]   [Full Text] [Related]  

  • 15. Staging: what makes sense? Can the pathologist help?
    Bernick PE; Wong WD
    Surg Oncol Clin N Am; 2000 Oct; 9(4):703-20; discussion 721-3. PubMed ID: 11008235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour markers - new aspects of an old discussion?
    Fleischhacker M; Beinert T
    Eur J Med Res; 1999 Apr; 4(4):144-8. PubMed ID: 10205289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumour markers in ovarian tumours.
    von Schlippe M; Rustin GJ
    Forum (Genova); 2000; 10(4):383-92. PubMed ID: 11535987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker profiling for cancer diagnosis, prognosis and therapeutic management.
    Mitra AP; Lin H; Cote RJ; Datar RH
    Natl Med J India; 2005; 18(6):304-12. PubMed ID: 16483031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetics and the surgeon: an invaluable tool in diagnosis, prognosis and counselling of patients with solid tumours.
    Humphrey GM; Squire R; Lansdown M; Markham A; MacLennan K
    Br J Surg; 1998 Jun; 85(6):725-34. PubMed ID: 9667696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.